MRG006A, a novel glypican-3-targeting antibody-drug conjugate, demonstrated potent anti-tumor activity and good safety profile in preclinical studies

被引：0
|
作者：
Wang, Yanchun
Li, Hongfeng
Shen, Hao
Liu, Wenchao
Liu, Shoujia
Yin, Kequan
Xu, Haili
Cui, Xueyuan
Li, Wei
Liu, Wei
Wu, Xiangyu
Yang, Liu
Ma, Tian
Zhao, Zhongrun
Wang, Jun
Cui, Feifei
Fang, Lei
Qin, Minmin
Hu, Chaohong
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3124
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3124
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A novel antibody-drug conjugate, HcHAb18-DM1, has potent anti-tumor activity against human non-small cell lung cancer
    Huhe, Muren
    Lou, Jiaxin
    Zhu, Yumeng
    Zhao, Yu
    Shi, Ying
    Wang, Bo
    Sun, Xiuxuan
    Zhang, Xiaoqin
    Zhang, Yang
    Chen, Zhi-Nan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 513 (04) : 1083 - 1091
  • [22] LY3076226, a novel anti-FGFR3 antibody drug conjugate exhibits potent and durable anti-tumor activity in tumor models harboring FGFR3 mutations or fusions
    Surguladze, David
    Pennello, Anthony
    Ren, Xiaodi
    Mack, Tim
    Rigby, Alan
    Balderes, Paul
    Navarro, Elizabeth
    Amaladas, Nelusha
    Eastman, Scott
    Topper, Michael
    Yao, Yung-Mae
    Moxham, Chris
    Plowman, Gregory
    Ludwig, Dale
    CANCER RESEARCH, 2019, 79 (13)
  • [23] DS-6000a, a novel CDH6-targeting antibody-drug conjugate with a novel DNA topoisomerase I inhibitor DXd, demonstrates potent antitumor activity in preclinical models
    Suzuki, H.
    Nagase, S.
    Saito, C.
    Nagata, M.
    Kaneda, Y.
    Honda, K.
    Nishiya, Y.
    Honda, T.
    Nakada, T.
    Goto, R.
    Ishizaka, T.
    Myobatake, Y.
    Abe, Y.
    Agatsuma, T.
    ANNALS OF ONCOLOGY, 2021, 32 : S363 - S364
  • [24] A novel EGFR x HER3-targeting bispecific antibody drug-conjugate, BCG019, demonstrates robust anti-tumor efficacy in preclinical evaluation
    Li, Zhuolin
    Shang, Chengzhang
    An, Gao
    Guo, Chaoshe
    An, W. Frank
    Yang, Yi
    CANCER RESEARCH, 2024, 84 (06)
  • [25] SGN-CD30C, a new CD30-directed camptothecin antibody-drug conjugate (ADC), shows strong anti-tumor activity and superior tolerability in preclinical studies
    Ryan, Maureen
    Lyski, Ryan
    Bou, Lauren
    Meyer, David
    Jin, Steven
    Simmons, Jessica
    Benjamin, Dennis
    Senter, Peter
    Jeffrey, Scott
    CANCER RESEARCH, 2020, 80 (16)
  • [26] DS-1062a, a novel TROP2-targeting antibody-drug conjugate with a novel DNA topoisomerase I inhibitor DXd, demonstrates potent antitumor activity in preclinical models
    Okajima, Daisuke
    Yamaguchi, Junko
    Kitamura, Michiko
    Kamei, Reiko
    Maejima, Takanori
    Shibutani, Tomoko
    Yasuda, Satoru
    Toki, Tadashi
    Karibe, Tsuyoshi
    Fujitani, Tomomichi
    Nakada, Takashi
    Goto, Riki
    Noguchi, Yutaka
    Abe, Yuki
    Agatsuma, Toshinori
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [27] BCG022, a novel HER3 x MET bispecific antibody-drug conjugate (bsADC), demonstrates promising anti-tumor efficacy
    Li, Zhuolin
    Shang, Chengzhang
    Han, Zhenyan
    An, Gao
    Guo, Chaoshe
    An, W. Frank
    Yang, Yi
    CANCER RESEARCH, 2024, 84 (06)
  • [28] The Trop-2-targeting antibody drug conjugate DB-1305 has higher anti-tumor activity and a potentially better safety profile compared with DS-1062
    Zhang, Y.
    Li, B.
    Shi, R.
    Qiu, Y.
    Zhong, C.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S91 - S92
  • [29] Novel folate receptor alpha-directed antibody-drug conjugate PRO1184 demonstrates broad antitumor activity with a promising safety profile in preclinical models
    Wang, Lei
    Liu, Haidong
    Zhou, Chang
    Han, Tae
    Zhao, Baiteng
    Chen, Zhu
    CANCER RESEARCH, 2023, 83 (07)
  • [30] RGX-019-MMAE, a novel MERTK-targeting antibody-drug conjugate (ADC) with robust anti-tumor efficacy in both solid and liquid tumors.
    Takeda, Shugaku
    Lo, PuiChi
    Schefer, Daniel
    Andreu-Agullo, Celia
    Battula, Venkata Lokesh
    Maiti, Abhishek
    Tavazoie, Masoud
    Darst, David Martin
    Kurth, Isabel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345